Europe Microbiome Therapeutics Market
The Europe Microbiome Therapeutics Market size was valued at US$ 97.74 Mn in 2022 and is projected to reach US$ 212.52 Mn by 2030, growing at a CAGR of 10.2% during 2022 - 2030.
Report Coverage
- Type: Therapeutics and Procedure
- Application: Metabolic Disorder and Obesity, C. Difficile Infection, Inflammatory Bowel Disease
- End User: Hospitals and Clinics, Ambulatory Surgical Centers, Homecare
US$ 97.74 Mn
Market size in 2022
US$ 212.52 Mn
Market Size by 2030
10.2%
CAGR, 2022 - 2030
2023-2030
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Microbiome Therapeutics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Microbiome Therapeutics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Microbiome Therapeutics Market Regional Analysis
6.2 Europe Microbiome Therapeutics Market Revenue 2020-2030 (US$ Million)
6.3 Europe Microbiome Therapeutics Market Forecast Analysis
7. Europe Microbiome Therapeutics Market Analysis – by Type
7.1 Therapeutics and Procedure
- 7.1.1 Overview
- 7.1.2 Therapeutics and Procedure: Europe Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Europe Microbiome Therapeutics Market Analysis – by Application
8.1 Metabolic Disorder and Obesity
- 8.1.1 Overview
- 8.1.2 Metabolic Disorder and Obesity: Europe Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 C. Difficile Infection
- 8.2.1 Overview
- 8.2.2 C. Difficile Infection: Europe Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Inflammatory Bowel Disease
- 8.3.1 Overview
- 8.3.2 Inflammatory Bowel Disease: Europe Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Europe Microbiome Therapeutics Market Analysis – by End User
9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals and Clinics: Europe Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Ambulatory Surgical Centers
- 9.2.1 Overview
- 9.2.2 Ambulatory Surgical Centers: Europe Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Homecare
- 9.3.1 Overview
- 9.3.2 Homecare: Europe Microbiome Therapeutics Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Europe Microbiome Therapeutics Market – Europe Analysis
10.1 Overview
10.2 Europe- 10.2.1 Europe Microbiome Therapeutics Market Breakdown, by Key Country, 2023 and 2030 (%)
- 10.2.1.1 Europe Microbiome Therapeutics Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 UK: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 UK: Europe Microbiome Therapeutics Market Breakdown, by Type
- 10.2.1.1.2 UK: Europe Microbiome Therapeutics Market Breakdown, by Application
- 10.2.1.1.3 UK: Europe Microbiome Therapeutics Market Breakdown, by End User
- 10.2.1.2 Germany: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.2.1 Germany: Europe Microbiome Therapeutics Market Breakdown, by Type
- 10.2.1.2.2 Germany: Europe Microbiome Therapeutics Market Breakdown, by Application
- 10.2.1.2.3 Germany: Europe Microbiome Therapeutics Market Breakdown, by End User
- 10.2.1.3 France: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.3.1 France: Europe Microbiome Therapeutics Market Breakdown, by Type
- 10.2.1.3.2 France: Europe Microbiome Therapeutics Market Breakdown, by Application
- 10.2.1.3.3 France: Europe Microbiome Therapeutics Market Breakdown, by End User
- 10.2.1.4 Russia: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.4.1 Russia: Europe Microbiome Therapeutics Market Breakdown, by Type
- 10.2.1.4.2 Russia: Europe Microbiome Therapeutics Market Breakdown, by Application
- 10.2.1.4.3 Russia: Europe Microbiome Therapeutics Market Breakdown, by End User
- 10.2.1.5 Italy: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.5.1 Italy: Europe Microbiome Therapeutics Market Breakdown, by Type
- 10.2.1.5.2 Italy: Europe Microbiome Therapeutics Market Breakdown, by Application
- 10.2.1.5.3 Italy: Europe Microbiome Therapeutics Market Breakdown, by End User
- 10.2.1.6 Rest of Europe: Europe Microbiome Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown, by Type
- 10.2.1.6.2 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown, by Application
- 10.2.1.6.3 Rest of Europe: Europe Microbiome Therapeutics Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Caelus Health BV
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Enterome SA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Ferring Holdings SA
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Vedanta Biosciences Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 YSOPIA Bioscience SA
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full E Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
